combination immunotherapy

Pharmaceuticals

Research studies on combination immunotherapy - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.

Loading research data...

Explore The Full Database

Related Terms

combination immunotherapy including therapeutic vaccination with HIV Gag conserved element-targeted DNA + IL-12 prime/modified vaccinia Ankara (MVA) boost regimen, administration of two bNAbs (10-1074, VRC07-523LS) and a toll-like receptor 9 agonist (lefitolimod) during ART suppression, followed by repeat bNAb administration at the time of ART interruption